| dbo:abstract
|
- Andreas Plückthun (born May 7, 1956) is a scientist whose research is focused on the field of protein engineering. Andreas Plückthun is the director of the department of biochemistry at the University of Zurich. Plückthun was appointed to the faculty of the University of Zurich as a Full professor of biochemistry in 1993. Plückthun was group leader at the Max Planck Institute of Biochemistry , Germany (1985-1993). He was elected to the European Molecular Biology Organization (EMBO) in 1992, and named a member of the German National Academy of Science (Leopoldina) in 2003. He is cofounder of the biotechnology companies Morphosys (Martinsried, Germany) Molecular Partners AG (Zürich-Schlieren, Switzerland) and G7 Therapeutics. (Zürich-Schlieren, Switzerland). Plückthun is a member of the board directors of the Antibody Society. His work is highly cited in the field of antibody engineering. He has been honoured by a number of international awards. (en)
- Andreas Plückthun (* 7. Mai 1956) ist ein deutscher Biochemiker, dessen Forschung sich auf das Gebiet des Protein-Engineering fokussiert. Er ist Professor am Biochemischen Institut der Universität Zürich. Er wurde 1992 zum Mitglied der European Molecular Biology Organization (EMBO) gewählt und 2003 in die Nationale Akademie der Wissenschaften (Leopoldina). aufgenommen. Er ist auch Mitgründer der Biotechnologiefirmen MorphoSys AG (Martinsried, Deutschland), Molecular Partners AG (Zürich-Schlieren, Schweiz) und G7 Therapeutics (Zürich-Schlieren, Schweiz). (de)
- Andreas Plückthun (né le 7 mai 1956) est un scientifique allemand dont les recherches se concentrent sur le domaine de l'ingénierie des protéines. (fr)
|
| dbo:academicDiscipline
| |
| dbo:award
| |
| dbo:birthDate
| |
| dbo:birthPlace
| |
| dbo:knownFor
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 9723 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:birthDate
| |
| dbp:birthPlace
| |
| dbp:field
| |
| dbp:knownFor
| |
| dbp:name
| |
| dbp:prizes
|
- Senior Investigator Grant of the European Research Council, Wilhelm-Exner Medal (en)
|
| dbp:wikiPageUsesTemplate
| |
| dbp:workInstitutions
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Andreas Plückthun (* 7. Mai 1956) ist ein deutscher Biochemiker, dessen Forschung sich auf das Gebiet des Protein-Engineering fokussiert. Er ist Professor am Biochemischen Institut der Universität Zürich. Er wurde 1992 zum Mitglied der European Molecular Biology Organization (EMBO) gewählt und 2003 in die Nationale Akademie der Wissenschaften (Leopoldina). aufgenommen. Er ist auch Mitgründer der Biotechnologiefirmen MorphoSys AG (Martinsried, Deutschland), Molecular Partners AG (Zürich-Schlieren, Schweiz) und G7 Therapeutics (Zürich-Schlieren, Schweiz). (de)
- Andreas Plückthun (né le 7 mai 1956) est un scientifique allemand dont les recherches se concentrent sur le domaine de l'ingénierie des protéines. (fr)
- Andreas Plückthun (born May 7, 1956) is a scientist whose research is focused on the field of protein engineering. Andreas Plückthun is the director of the department of biochemistry at the University of Zurich. Plückthun was appointed to the faculty of the University of Zurich as a Full professor of biochemistry in 1993. Plückthun was group leader at the Max Planck Institute of Biochemistry , Germany (1985-1993). He was elected to the European Molecular Biology Organization (EMBO) in 1992, and named a member of the German National Academy of Science (Leopoldina) in 2003. He is cofounder of the biotechnology companies Morphosys (Martinsried, Germany) Molecular Partners AG (Zürich-Schlieren, Switzerland) and G7 Therapeutics. (Zürich-Schlieren, Switzerland). (en)
|
| rdfs:label
|
- Andreas Plückthun (en)
- Andreas Plückthun (de)
- Andreas Plückthun (fr)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
